|Articles|February 23, 2018
Express Scripts, Walgreens Group Purchasing Partnership Highlights SPT Week in Review
Author(s)SPT Staff
Top news of the week from Specialty Pharmacy Times.
Advertisement
5. Modified Antiviral Drug Could Cure HIV
Crystalized dolutegravir may be able to reach viral reservoirs and cure HIV.
4. Oncolytic Viruses Put Immune System on High Alert
Combining oncolytic viruses and immunotherapies may fight cancer more effectively.
3. Brain Stimulation May Relieve Multiple Sclerosis-Associated Fatigue
Deep transcranial stimulation could provide more relief from fatigue among multiple sclerosis patients compared with other treatments.
2. Enzalutamide Meets Phase 3 Endpoints in Prostate Cancer
Enzalutamide (Xtandi) demonstrates a significant reduction in metastasis or death from castration-resistant prostate cancer.
1. Express Scripts, Walgreens Partner to Expand Group Purchasing of Specialty Drugs
The new purchasing efforts may help increase biosimilar uptake and lower drug costs.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
Young Women With Symptomatic Long COVID At Higher Risk of POTS
3
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
4
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
5
